Fannin Partners

Funding rounds backed by Fannin Partners.

Export CSV
Funding disclosed in full
$6.5M
Median round
$6.5M
Rounds in calculation
1
1 round
LatestLargest
Funding rounds with company descriptions, amounts, stages and announcement dates
CompanyRoundMarketInvestorsAnnouncedDetails
Goldenrod Therapeutics

Develops novel brain-penetrant therapies targeting neuroinflammation and neuronal signaling pathways

$6.5MSeedBiotechUnited States
2 participantsAtaxia VenturesFannin Partners